ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANIP POWR Grades

• ANIP scores best on the Growth dimension, with a Growth rank ahead of 95.87% of US stocks.
• The strongest trend for ANIP is in Growth, which has been heading up over the past 179 days.
• ANIP's current lowest rank is in the Quality metric (where it is better than 5.83% of US stocks).

ANIP Stock Summary

• With a year-over-year growth in debt of 41.95%, ANI PHARMACEUTICALS INC's debt growth rate surpasses 77.98% of about US stocks.
• In terms of twelve month growth in earnings before interest and taxes, ANI PHARMACEUTICALS INC is reporting a growth rate of 257.84%; that's higher than 93.43% of US stocks.
• ANI PHARMACEUTICALS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.42%, greater than the shareholder yield of only 18.46% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ANI PHARMACEUTICALS INC are TKNO, JMIA, KPLT, MRAI, and CBT.
• ANIP's SEC filings can be seen here. And to visit ANI PHARMACEUTICALS INC's official web site, go to www.anipharmaceuticals.com.

ANIP Valuation Summary

• ANIP's EV/EBIT ratio is -15.2; this is 276.74% lower than that of the median Healthcare stock.
• Over the past 243 months, ANIP's EV/EBIT ratio has gone down 12.4.

Below are key valuation metrics over time for ANIP.

ANIP Growth Metrics

Its 2 year cash and equivalents growth rate is now at 222.28%.
• Its 4 year price growth rate is now at -35.19%.
• Its 3 year cash and equivalents growth rate is now at 89.43%.

Over the past 70 months, ANIP's revenue has gone up $154,460,000.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	283.082	-38.988	-69.197
2022-06-30	251.322	-48.013	-64.638
2022-03-31	226.092	-36.288	-63.414
2021-12-31	216.136	3.322	-42.793
2021-09-30	212.459	9.798	-22.102
2021-06-30	213.377	13.586	-17.221

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
• ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
• NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.